1 LATANOPROST | 10 of 2460 | 1,7920 prescriptions Less than 1% of all prescriptions | 1,7760 | 3840 patients 42% of all patients | < 11 | |
2 TIMOLOL MALEATE | 20 of 2250 | 6470 prescriptions Less than 1% of all prescriptions | | 2350 patients 26% of all patients | < 11 | |
3 DORZOLAMIDE-TIMOLOL (DORZOLAMIDE HCL/TIMOLOL MALEAT) | 70 of 2040 | 3510 prescriptions Less than 1% of all prescriptions | 3510 | 990 patients 11% of all patients | 990 patients 11% of all patients | |
4 PREDNISOLONE ACETATE | 40 of 2220 | 6340 prescriptions Less than 1% of all prescriptions | 6230 | 2860 patients 31% of all patients | < 11 | |
5 DORZOLAMIDE HCL | 60 of 1440 | 2380 prescriptions Less than 1% of all prescriptions | | 840 patients 9% of all patients | < 11 | |
6 BRIMONIDINE TARTRATE | 50 of 1580 | 3070 prescriptions Less than 1% of all prescriptions | | 770 patients 8% of all patients | < 11 | |
7 COMBIGAN (BRIMONIDINE TARTRATE/TIMOLOL) | 60 of 2040 | 3120 prescriptions Less than 1% of all prescriptions | 3120 | 660 patients 7% of all patients | 660 patients 7% of all patients | |
8 ALPHAGAN P (BRIMONIDINE TARTRATE) | 20 of 1510 | 2450 prescriptions Less than 1% of all prescriptions | 2450 | 560 patients 6% of all patients | 560 patients 6% of all patients | |
9 AZOPT (BRINZOLAMIDE) | 30 of 1260 | 1870 prescriptions Less than 1% of all prescriptions | 1870 | 520 patients 6% of all patients | 520 patients 6% of all patients | |
10 TRAVATAN Z (TRAVOPROST) | 150 of 1900 | 2010 prescriptions Less than 1% of all prescriptions | | 590 patients 6% of all patients | < 11 | |
11 LUMIGAN (BIMATOPROST) | 320 of 1950 | 2060 prescriptions Less than 1% of all prescriptions | 2060 | 450 patients 5% of all patients | 450 patients 5% of all patients | |
12 OFLOXACIN | 50 of 900 | 3010 prescriptions Less than 1% of all prescriptions | 3010 | 1930 patients 21% of all patients | 1930 patients 21% of all patients | A |
13 PILOCARPINE HCL | 20 of 400 | 880 prescriptions Less than 1% of all prescriptions | 880 | 270 patients 3% of all patients | 270 patients 3% of all patients | |
14 SIMBRINZA (BRINZOLAMIDE/BRIMONIDINE TART) | 160 of 1130 | 800 prescriptions Less than 1% of all prescriptions | | 210 patients 2% of all patients | < 11 | |
15 RHOPRESSA (NETARSUDIL MESYLATE) | 30 of 320 | 780 prescriptions Less than 1% of all prescriptions | | 380 patients 4% of all patients | < 11 | |
16 DUREZOL (DIFLUPREDNATE) | 540 of 1170 | 600 prescriptions Less than 1% of all prescriptions | | 330 patients 4% of all patients | < 11 | |
17 KETOROLAC TROMETHAMINE | 340 of 1040 | 510 prescriptions Less than 1% of all prescriptions | | 200 patients 2% of all patients | < 11 | |
18 ACETAZOLAMIDE | 100 of 420 | 370 prescriptions Less than 1% of all prescriptions | 370 | < 11 | < 11 | |
19 ATROPINE SULFATE | 10 of 200 | 380 prescriptions Less than 1% of all prescriptions | 380 | 260 patients 3% of all patients | 260 patients 3% of all patients | |
20 LEVOBUNOLOL HCL | 70 of 150 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 BETAXOLOL HCL | 30 of 50 | 240 prescriptions Less than 1% of all prescriptions | 240 | < 11 | < 11 | |
22 ZIOPTAN (TAFLUPROST/PF) | 160 of 370 | 210 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
23 BETIMOL (TIMOLOL) | 200 of 300 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
24 COSOPT PF (DORZOLAMIDE/TIMOLOL/PF) | 200 of 490 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
25 LOTEMAX (LOTEPREDNOL ETABONATE) | 390 of 1010 | 220 prescriptions Less than 1% of all prescriptions | 220 | < 11 | < 11 | |
26 ISTALOL (TIMOLOL MALEATE) | 100 of 140 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
27 ERYTHROMYCIN (ERYTHROMYCIN BASE) | 580 of 1340 | 220 prescriptions Less than 1% of all prescriptions | | 190 patients 2% of all patients | < 11 | A |
28 NEOMYCIN-POLYMYXIN-DEXAMETH (NEOMYCIN/POLYMYXIN B/DEXAMETHA) | 610 of 1220 | 200 prescriptions Less than 1% of all prescriptions | 200 | 180 patients 2% of all patients | 180 patients 2% of all patients | |